IL281660A - A high-affinity T-cell receptor for AFP antigen recognition - Google Patents

A high-affinity T-cell receptor for AFP antigen recognition

Info

Publication number
IL281660A
IL281660A IL281660A IL28166021A IL281660A IL 281660 A IL281660 A IL 281660A IL 281660 A IL281660 A IL 281660A IL 28166021 A IL28166021 A IL 28166021A IL 281660 A IL281660 A IL 281660A
Authority
IL
Israel
Prior art keywords
high affinity
cell receptor
afp antigen
recognizing
recognizing afp
Prior art date
Application number
IL281660A
Other languages
English (en)
Hebrew (he)
Inventor
Yi Li
Xiaolin Li
Shaopei Chen
Original Assignee
Xlifesc Ltd
Yi Li
Xiaolin Li
Shaopei Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xlifesc Ltd, Yi Li, Xiaolin Li, Shaopei Chen filed Critical Xlifesc Ltd
Publication of IL281660A publication Critical patent/IL281660A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/60Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622Single chain antibody (scFv)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL281660A 2018-09-21 2021-03-21 A high-affinity T-cell receptor for AFP antigen recognition IL281660A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811109677 2018-09-21
PCT/CN2019/106816 WO2020057619A1 (zh) 2018-09-21 2019-09-19 一种识别afp抗原的高亲和力t细胞受体

Publications (1)

Publication Number Publication Date
IL281660A true IL281660A (en) 2021-05-31

Family

ID=69888304

Family Applications (1)

Application Number Title Priority Date Filing Date
IL281660A IL281660A (en) 2018-09-21 2021-03-21 A high-affinity T-cell receptor for AFP antigen recognition

Country Status (10)

Country Link
US (1) US12275773B2 (https=)
EP (1) EP3854802A4 (https=)
JP (1) JP7505785B2 (https=)
KR (1) KR20210108941A (https=)
CN (1) CN110938136B (https=)
AU (1) AU2019344871B2 (https=)
CA (1) CA3113536A1 (https=)
IL (1) IL281660A (https=)
SG (1) SG11202102903QA (https=)
WO (1) WO2020057619A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113621070A (zh) 2020-05-06 2021-11-09 华夏英泰(北京)生物技术有限公司 一种t细胞抗原受体、其多聚体复合物及其制备方法和应用
CN113667008A (zh) * 2020-05-15 2021-11-19 香雪生命科学技术(广东)有限公司 一种识别afp抗原的高亲和力t细胞受体
CN119930796B (zh) * 2025-04-10 2025-09-16 恒瑞源正(广州)生物科技有限公司 一种t细胞受体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2645256C2 (ru) 2013-06-26 2018-02-19 Гуандун Сянсюэ Лайф Сайенсис, Лтд. Высокостабильный т-клеточный рецептор и способ его получения и применения
GB201313377D0 (en) * 2013-07-26 2013-09-11 Adaptimmune Ltd T cell receptors
CN104087592B (zh) * 2014-05-13 2016-01-27 天津医科大学总医院 Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途
AU2016243026B2 (en) * 2015-04-03 2022-03-31 Eureka Therapeutics, Inc. Constructs targeting AFP peptide/MHC complexes and uses thereof
CN106459178B (zh) * 2015-09-09 2018-06-12 广东香雪精准医疗技术有限公司 针对rhamm抗原短肽的高亲和力t细胞受体
CN106519019B (zh) * 2015-11-06 2018-07-03 广东香雪精准医疗技术有限公司 识别prame抗原的tcr
GB201604494D0 (en) 2016-03-16 2016-04-27 Immatics Biotechnologies Gmbh Transfected T-Cells and T-Cell receptors for use in immunotherapy against cancers
GB201608052D0 (en) * 2016-05-09 2016-06-22 Univ Oslo Hf T-cell receptors which recognise frameshift mutants of TGF-beta RII
CN108264550B (zh) * 2017-01-04 2021-04-23 香雪生命科学技术(广东)有限公司 一种识别源自于prame抗原短肽的tcr
CN109575121B (zh) * 2017-09-28 2022-09-09 香雪生命科学技术(广东)有限公司 识别afp抗原短肽的t细胞受体

Also Published As

Publication number Publication date
US12275773B2 (en) 2025-04-15
CN110938136A (zh) 2020-03-31
KR20210108941A (ko) 2021-09-03
EP3854802A4 (en) 2022-10-12
WO2020057619A1 (zh) 2020-03-26
JP7505785B2 (ja) 2024-06-25
JP2022502078A (ja) 2022-01-11
AU2019344871B2 (en) 2025-04-03
AU2019344871A1 (en) 2021-05-20
US20220033458A1 (en) 2022-02-03
SG11202102903QA (en) 2021-04-29
AU2019344871A2 (en) 2021-06-17
CN110938136B (zh) 2022-09-09
EP3854802A1 (en) 2021-07-28
CA3113536A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
IL280780A (en) Anti-TIGIT antibodies
ZA202101537B (en) Anti-trem-2 agonist antibodies
IL276746A (en) Kir3dl3 as hhla2 receptor, anti-hhla2 antibodies and their uses
IL280013A (en) Anti-IL36R antibodies
IL276397A (en) Antibodies specific to CD70 and their uses
IL279352A (en) IL-11RA antibodies
SG11201708061TA (en) Antibodies directed against interleukin 36 receptor (il-36r)
SG10202107165XA (en) Anti-transferrin receptor antibodies with tailored affinity
SG11202000606TA (en) Reagents for expanding cells expressing recombinant receptors
MX376026B (es) Inmunoreceptores especificos de claudina-6 y epitopos de celulas t.
EP3831845A4 (en) T-LYMPHOCYTE RECEPTOR TO IDENTIFY AN AFP ANTIGEN
IL278010A (en) Antibodies to galectin 10
GB202110263D0 (en) Anti-btla antibodies
IL277946A (en) Chimeric antigen receptors for the interleukin-23 receptor
IL277030A (en) Antibodies
GB2551945B (en) Novel GLP-1 receptor agonist peptides
IL281660A (en) A high-affinity T-cell receptor for AFP antigen recognition
SG11202102114UA (en) Anti-klrg1 antibodies
GB201806084D0 (en) Antibodies
IL277510A (en) Anti-137CD antibodies for combination with anti-L1-PD antibodies
GB201817676D0 (en) T cell antigen receptor chimera
GB201721831D0 (en) T cell antigen receptor chimera
SG11202105718TA (en) Modified antibodies
GB201917059D0 (en) Hybrid antibody
GB201914165D0 (en) Hybrid antibody